Extending the Product Label for Ticagrelor: Looking Under the FDA Hood.

Armstrong, Paul W

Armstrong, Paul W.

Armstrong PW; Canadian VIGOUR (Virtual Coordinating Centre for Global Collaborative Cardiovascular Research) Centre and Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Canada.

Circulation ; 144(8): 583-585, 2021 08 24.

Article en En | MEDLINE | ID: mdl-34424765

Asunto(s)

Inhibidores de Agregación Plaquetaria; Humanos; Inhibidores de Agregación Plaquetaria/efectos adversos; Ticagrelor/efectos adversos; Estados Unidos; United States Food and Drug Administration

Palabras clave

United States Food and Drug Administration; drug labeling; ticagrelor

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Agregación Plaquetaria Límite: Humans País como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google